AB Science S.A. (LON:0Q77)
London · Delayed Price · Currency is GBP · Price in EUR 1.342
-0.086 (-6.02%)
At close: Feb 11, 2026
AB Science Market Cap
AB Science has a market cap or net worth of 84.52 million as of February 12, 2026. Its market cap has increased by 3.21% in one year.
Market Cap
84.52M
Enterprise Value
96.75M
Revenue
880.34K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.34
Market Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 329.29M to 84.52M, a decrease of -74.33%. That is a compound annual growth rate of -8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 84.52M | -13.53% |
| Dec 31, 2025 | 97.75M | 105.39% |
| Dec 31, 2024 | 47.59M | -69.69% |
| Dec 29, 2023 | 157.00M | -46.73% |
| Dec 30, 2022 | 294.70M | -37.60% |
| Dec 31, 2021 | 472.28M | -41.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| EKF Diagnostics Holdings | 107.56M |
| Bioventix | 90.13M |
| Venture Life Group | 87.68M |
| 4basebio | 86.67M |